SCHEMBL12770895

SCHEMBL12770895

Cc1cc(Pc2ccccc2/C=N/c2ccccc2)c(O)c(C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ CA2 P00918 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ TYR P14679 1/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.39
▸ MAPT P10636 4/20 0.38
▸ MAOB P27338 4/20 0.36
▸ ALOX12 P18054 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HSPA5 P11021 1/20 0.35
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ PLA2G1B P04054 1/20 0.34
▸ ATG4B Q9Y4P1 1/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12770918 0.91 MAOB (0.44) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL12770900 0.88 ALOX5 (0.43) ALDH1A1CA2SIRT2MAPTMAOB
SCHEMBL12770886 0.86 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL12770970 0.86 MAOB (0.39) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL12770963 0.85 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL12770896 0.85 SIRT2 (0.43) ALDH1A1SMN1; SMN2CA2POLBSIRT2
SCHEMBL12336953 0.82 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL12770901 0.82 SIRT2 (0.40) ALDH1A1SMN1; SMN2CA2POLBSIRT2
SCHEMBL12770915 0.82 MAOB (0.43) ALDH1A1CA2SIRT2MAPTMAOB
SCHEMBL12771005 0.81 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2CA2POLBTYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915455-B2 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-29 — — US disclosed
US-20090143620-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED 2009-06-04 — — US disclosed
US-7482414-B2 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-27 — — US disclosed
US-20070135600-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135600-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex AP1M1, OR10J3, AP2M1 ALDH1A1 4017/4885SMN1; SMN2 2171/4885CA2 1200/4885
US-20090143620-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex AP1M1, OR10J3, AP2M1 ALDH1A1 4017/4885SMN1; SMN2 2171/4885CA2 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback